Skip to main content

Closed

ADIL: Adial Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

19thpctl

Volume

0.11×avg

Market Cap

3.21MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Adial Pharmaceuticals, Inc.

ADILNASDAQ Capital Market·USD·Closed

Adial Pharmaceuticals, Inc.

ADILNASDAQ·USD·Closed

$3.34

+1.52%

$3.34

+$0.05 (1.52%)

52W Range

19thpctl

Volume

0.11×avg

Mkt Cap

3.21MUSD

P/E

-0.5TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings